Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer

Lewis J. Thomas,Ryan L. Steinberg,Vignesh T. Packiam,Ian M. McElree,Nathan Brooks,Andrew Vitale,Eric Hyndman,Trafford Crump,Mounica Y. Rao,Donald L. Lamm,Marcus J. Daniels,Max Kates,Supriya Nagaraju,Ashish M. Kamat,Trinity J. Bivalacqua,Sarah L. Mott,Kenneth G. Nepple,Michael A. O'Donnell

Clinical Genitourinary Cancer（2022）

引用 0|浏览5

暂无评分

摘要

•Due to production shortages, BCG has been precluded from many urological practices.•Gem/Doce is a safe and effective treatment for NMIBC.•Further prospective evaluation is underway.

查看译文

关键词

Urinary Bladder Neoplasms,Chemotherapy, Adjuvant,Gemcitabine,Docetaxel

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要